Croyle, Maria A <br/><br/>
Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.  [electronic resource] 

 -  PloS one  2008 
 - e3548 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0003548  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--immunology<br/>Administration, Intranasal<br/>Animals<br/>Antibody Formation--physiology<br/>Bronchoalveolar Lavage Fluid--chemistry<br/>Drug Delivery Systems--methods<br/>Ebola Vaccines--administration & dosage<br/>Ebolavirus--immunology<br/>Hemorrhagic Fever, Ebola--immunology<br/>Immunity, Mucosal--drug effects<br/>Immunotherapy, Active--methods<br/>Mice<br/>Mice, Inbred C57BL<br/>Polyethylene Glycols--chemistry<br/>Survival Analysis<br/>Virosomes--immunology